CD BioGlyco is a world-leading glycobiology research company that provides high-quality customized microarrays for research, diagnosis and treatment of all types of glycobiology. We provide innovative and flexible solutions for customized technology development. We have confidence to be your essential research assistant in the field of glycobiology.
We use industry-leading microarray to provide high-quality microarray services in a variety of different model organisms. With years of experience working on the microarray, our scientists use advanced technology platforms to help customers perform experiments such as design, quality control, scanning, and data analysis. We are good at providing new insights in the disease process and early drug development research (including drug discovery and target verification etc.), and provide strong technical support for customer research. We are a global company and a trusted partner in science.
Fig.1 Construction and screening of peptidoglycan (PGN) microarrays. (Tsouka, et al., 2025)
Our custom microarray printing services are based on advanced printing technology, enabling the precise printing of various biomolecules onto various solid substrates. Leveraging our expertise, we help create powerful customized screening tools. These custom microarrays are used in fields such as the discovery of novel biomarkers, validation of drug targets, and elucidation of complex signaling pathways.
Our custom microarray printing service is guided by an experienced team to ensure optimal results.
Technology: PGN microarray
Journal: Angewandte Chemie International Edition
IF: 16.8994
Published: 2025
Results: This graduate student generated multiple different polypeptides and linked several polysaccharides (the primary structural components of bacterial cell walls) to produce various PGN fragments. Ultimately, using a novel chip synthesis technology, a microarray containing hundreds of PGN fragments from Gram-positive and Gram-negative bacterial variants was generated. Researchers validated the array and its epitopes using four monoclonal antibodies and analyzed plasma samples from epidermolysis bullosa (EB) patients using these microarrays to validate the antibody profile. The results showed that surface functionalization of PGN plays a key role in IgG responses in patients. This study demonstrates the potential application of PGN microarrays in identifying specific antibody profiles targeting the human microbiome, particularly in intestinal diseases.
Fig. 2 Combined PGN microarray (Tsouka, et al., 2025)
CD BioGlyco provides advanced customized microarray printing services and thoughtful after-sales service. Professional experimenters and data analysts will provide guarantee for customer needs. With our high-quality services, we have won praise from customers all over the world.
Customers can contact our employees directly and we will respond promptly. If you are interested in our services, please contact us for more detailed information.
Reference